HSBC Holdings’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
65,174
+13,118
+25% +$285K ﹤0.01% 1847
2025
Q4
$1.37M Sell
52,056
-25,257
-33% -$655K ﹤0.01% 1755
2025
Q3
$1.74M Buy
77,313
+1,864
+2% +$38.4K ﹤0.01% 1555
2025
Q2
$1.49M Sell
75,449
-7,122
-9% -$139K ﹤0.01% 1606
2025
Q1
$1.4M Buy
82,571
+1,695
+2% +$28.9K ﹤0.01% 1601
2024
Q4
$1.49M Buy
80,876
+6,317
+8% +$123K ﹤0.01% 1604
2024
Q3
$1.61M Sell
74,559
-1,127
-1% -$25.2K ﹤0.01% 1510
2024
Q2
$1.51M Sell
75,686
-65
-0.1% -$1.36K ﹤0.01% 1501
2024
Q1
$1.64M Buy
75,751
+59,802
+375% +$1.49M ﹤0.01% 1575
2023
Q4
$466K Buy
15,949
+2,864
+22% +$76.6K ﹤0.01% 2077
2023
Q3
$349K Buy
+13,085
New +$447K ﹤0.01% 2145
2022
Q3
Sell
-5,190
Closed -$285K 3034
2022
Q2
$285K Sell
5,190
-462
-8% -$25.4K ﹤0.01% 2663
2022
Q1
$350K Buy
5,652
+1,833
+48% +$121K ﹤0.01% 2657
2021
Q4
$390K Sell
3,819
-4,407
-54% -$387K ﹤0.01% 2615
2021
Q3
$751K Sell
8,226
-795
-9% -$72.3K ﹤0.01% 2031
2021
Q2
$812K Sell
9,021
-9,416
-51% -$752K ﹤0.01% 1879
2021
Q1
$1.79M Buy
+18,437
New +$1.9M ﹤0.01% 1343

Other funds holding FLGT

HSBC Holdings's FLGT Position: Q1 2026 in Review

HSBC Holdings increased its Fulgent Genetics (FLGT) stake by 25% in Q1 2026, buying an estimated $285K and bringing the position to 65,174 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

HSBC Holdings first reported a position in FLGT in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.79M in Q1 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • HSBC Holdings held 65,174 shares of Fulgent Genetics worth $1.03M as of Q1 2026.
  • HSBC Holdings bought 13,118 Fulgent Genetics shares in Q1 2026, an estimated $285K.
  • Fulgent Genetics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1847 holding.
  • HSBC Holdings first reported a position in Fulgent Genetics in Q1 2021 and has held it in 17 quarters since.
  • HSBC Holdings's Fulgent Genetics position peaked at $1.79M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.